Full Press Release Details
Blog Post
| August 13, 2024
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
Read More
Previous Article
Next Article
Blog Navigation
VANI Neutral Sentiment
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
Key Takeaway: Vivani Medical has released a business update along with its financial results for the second quarter of 2024. The article provides insights into the company's performance and strategic direction. However, specific details regarding financial metrics or operational changes are not included in the text provided.
Price reaction · baseline $1.16 (2024-08-13 close) · hit after-hours · clean, no other VANI news in the window
day 0 close
+8.6%
day 1
+9.5%
day 3 · peak
+17.2%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight